journal
MENU ▼
Read by QxMD icon Read
search

American Journal of Therapeutics

journal
https://read.qxmd.com/read/30730330/aripiprazole-induced-late-neuroleptic-malignant-syndrome
#1
Ankit Agrawal, Divyansh Bajaj, Suryansh Bajaj, Joseph Mattana
No abstract text is available yet for this article.
February 1, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30741917/clozapine-might-relieve-rhinotillexomania-and-related-epistaxis-in-schizophrenia-patients-a-case-report
#2
Ching-Wen Chu, Chih-Sung Liang
No abstract text is available yet for this article.
January 30, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30741916/manganese-toxicity-complicating-parenteral-nutrition
#3
(no author information available yet)
No abstract text is available yet for this article.
January 30, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30730334/lisdexamfetamine-overdose
#4
Avram Flamm, Michelle A Hieger
No abstract text is available yet for this article.
January 29, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30730333/amphotericin-b-induced-hyperbilirubinemia
#5
Divyansh Bajaj, Soumya Thumma, Ankit Agrawal, Joseph Mattana
No abstract text is available yet for this article.
January 29, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30730332/psychotic-symptoms-related-to-the-prophylactic-use-of-levetiracetam-after-brain-surgery
#6
Po-Chun Lin, Chun-Yen Chen, Ching-Wen Chu, Yueh-Ming Tai, Dueng-Yuan Hueng, Nian-Sheng Tzeng
No abstract text is available yet for this article.
January 29, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30730331/use-of-direct-oral-anticoagulants-in-the-treatment-of-left-ventricular-thrombus-systematic-review-of-current-literature
#7
Marvin Kajy, Mohamed Shokr, Preeti Ramappa
BACKGROUND: Left ventricular thrombus (LVT) is an important complication in the setting of systolic dysfunction, particularly after acute myocardial infarction. Current guidelines recommend the vitamin-K antagonist, warfarin, for the treatment of LVT. AREA OF UNCERTAINTY AND STUDY QUESTION: The direct oral anticoagulants (DOACs) are being increasingly used for the management of this entity, despite lack of randomized trials in support of it or knowledge about their efficacy...
January 29, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30677005/consideration-of-potential-drug-drug-interactions-in-selection-of-fda-approved-drugs-indicated-for-prostate-cancer
#8
Dominic Pilon, Lorie A Ellis, Yongling Xiao, Ajay S Behl, Patrick Lefebvre
No abstract text is available yet for this article.
January 18, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30677004/effect-of-a-30-month-health-promoting-program-on-the-prevalence-of-cardiovascular-risk-factors-in-patients-with-first-episode-schizophrenia
#9
Hans J Søgaard, Mikkel Højlund, Anja Elliott, Anne G Viuff, Kirsten Vandborg, Jakob Viuff, Povl Munk-Jørgensen, Peter Hjorth
BACKGROUND: Lifestyle interventions aimed at reducing cardiovascular risk factors in patients with first-episode schizophrenia (FES) have shown modest efficacy, probably owing to a short observation period and the presumption of linear trajectories of cardiovascular risk factors. STUDY QUESTION: How prevalent are abnormal cardiovascular values in patients with FES and how do cardiovascular risk factors develop during a 30-month program? STUDY DESIGN: A 30-month naturalistic longitudinal study of 136 consecutively referred patients with FES from 2 outpatient clinics...
January 18, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30664522/albuterol-induced-lactic-acidosis
#10
Karan N Ramakrishna, Jaswinder Virk, Harvir Singh Gambhir
No abstract text is available yet for this article.
January 16, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30664018/efficacy-of-sacubitril-valsartan-in-hypertension
#11
Aaqib H Malik, Wilbert S Aronow
BACKGROUND: Sacubitril/valsartan (LCZ696) has progressed to be one of the most promising medication since its approval for chronic heart failure with reduced ejection fraction. Recent data have suggested a superior blood pressure control with LCZ696. STUDY QUESTION: What is the antihypertensive efficacy and safety profile of sacubitril/valsartan? DATA SOURCES: Randomized controlled trials (RCTs) comparing the efficacy and safety of LCZ696 against a placebo or angiotensin receptor blocker (ARB)...
January 10, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30648990/efficacy-of-intranasal-insulin-in-improving-cognition-in-mild-cognitive-impairment-and-alzheimer-disease-a-systematic-review-and-meta-analysis
#12
Jian Lu, Zhongye Xu
No abstract text is available yet for this article.
January 3, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30648989/acute-autoimmune-leukoencephalopathy-secondary-to-adalimumab-therapy
#13
Parthvi Rukma
No abstract text is available yet for this article.
January 3, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30648988/glucagon-for-refractory-anaphylaxis
#14
Parthvi Rukma
No abstract text is available yet for this article.
January 3, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30648987/elevations-in-high-sensitive-cardiac-troponin-t-and-n-terminal-prohormone-brain-natriuretic-peptide-levels-in-the-serum-can-predict-the-development-of-anthracycline-induced-cardiomyopathy
#15
Alina Bisoc, Daniel Ciurescu, Mariana Rădoi, Monica M Tântu, Liliana Rogozea, Alexander J Sweidan, Daniela A Bota
BACKGROUND: Anthracyclines remain the cornerstone of the treatment in many cancers including lymphomas, leukemia and sarcomas, and breast cancer. The cardiomyopathy that develops from anthracyclines can lead to heart failure and decreased survival. Multiple mechanisms are involved in the pathophysiology of anthracycline-induced heart failure. STUDY QUESTION: We hypothesize that anthracycline-induced cardiac (AIC) pathology can be monitored using a panel of blood biomarkers including high-sensitive cardiac troponin T (hs-cTnT) for myocyte necrosis and N-terminal prohormone brain natriuretic peptide (NT-proBNP) for parietal stress...
January 3, 2019: American Journal of Therapeutics
https://read.qxmd.com/read/30601177/a-new-safety-scoring-system-for-the-use-of-psychotropic-drugs-during-lactation
#16
Faruk Uguz
BACKGROUND: Psychotropic drugs are frequently used to treat postpartum women with psychiatric diagnoses, especially psychotic disorder, major depression, and bipolar mood episodes. Pharmacotherapy in breastfeeding mothers is a major challenge. STUDY QUESTION: This article presents a new safety scoring system for the use of psychotropic drugs during lactation. STUDY DESIGN: The scoring system is based on the following 6 safety parameters: reported total sample, reported maximum relative infant dose, reported sample size for relative infant dose, infant plasma drug levels, prevalence of reported any adverse effect, and reported serious adverse effects...
December 26, 2018: American Journal of Therapeutics
https://read.qxmd.com/read/30601176/mirtazapine-for-inappropriate-sexual-behaviors-in-autism
#17
Ahmed Naguy, Fouziya Alrashidi, Sara R AlShalabi
No abstract text is available yet for this article.
December 26, 2018: American Journal of Therapeutics
https://read.qxmd.com/read/30601186/apatinib-as-salvage-treatment-in-brca2-mutated-advanced-lung-adenocarcinoma
#18
Da-Xiong Zeng, Jian-An Huang, Jun-Hong Jiang
No abstract text is available yet for this article.
December 20, 2018: American Journal of Therapeutics
https://read.qxmd.com/read/30601187/tetracycline-re-exposure-induced-toxic-epidermal-necrolysis
#19
Mayuri Kulkarni, Rovin Saxena, Benjamin Diaczok, Hazem Nassif
No abstract text is available yet for this article.
December 19, 2018: American Journal of Therapeutics
https://read.qxmd.com/read/30615598/comparative-therapeutic-assessment-of-atrial-fibrillation-in-heart-failure-with-reduced-ejection-fraction-a-network-meta-analysis
#20
Aaqib H Malik, Wilbert S Aronow
BACKGROUND: Catheter ablation (CA) continues to prove to be an intriguing therapeutic option for the management of atrial fibrillation (AF) especially in patients with heart failure with reduced ejection fraction (HFrEF). Recent data have suggested that CA may be a viable first-line strategy for these patients. STUDY QUESTION: Is CA more effective in managing patients with AF with HFrEF compared to optimal medical treatment and anti-arrhythmic drugs? DATA SOURCES: Randomized controlled trials (RCTs) comparing CA, medical treatment, or antiarrhythmic drugs to each other or a placebo group for the treatment of AF in HFrEF...
December 17, 2018: American Journal of Therapeutics
journal
journal
32115
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"